Onconic Therapeutics Inc. (KOSDAQ:476060)
22,000
-900 (-3.93%)
Apr 28, 2026, 3:30 PM KST
260.66% (1Y)
| Market Cap | 987.53B |
| Revenue (ttm) | 53.39B |
| Net Income (ttm) | 15.78B |
| Shares Out | 44.89M |
| EPS (ttm) | n/a |
| PE Ratio | 62.57 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 395,702 |
| Average Volume | 502,105 |
| Open | 22,650 |
| Previous Close | 22,900 |
| Day's Range | 21,900 - 22,650 |
| 52-Week Range | 5,000 - 28,900 |
| Beta | n/a |
| RSI | 49.19 |
| Earnings Date | Mar 20, 2026 |